Loading, please wait...

product description page

Conquering Ras : From Biology to Cancer Therapy (Hardcover) (Asfar Azmi)

Conquering Ras : From Biology to Cancer Therapy (Hardcover) (Asfar Azmi) - image 1 of 1

About this item

Conquering RAS: From Biology to Cancer Therapy provides introductory knowledge on how modern RAS biology is taking shape in light of newer technology development. Each chapter is written in a manner emphasizing simplicity and readability for both new investigators and established researchers. While RAS biology has been intensively studied for more than three decades, we are yet to see any effective therapeutics that could interfere in the signaling cascade regulated by this master oncogene.

Conquering RAS: From Biology to Cancer Therapy covers topics ranging from basic RAS biology to translational biology and drug discovery applications. These topics will be appealing to basic researchers working on the lab bench who seek deeper understanding of the modern concepts in RAS research. On the other side, the oncologist on patient’s bedside will find the book useful as they routinely face the daunting task of treating patients that predominantly have a disease driven by oncogenic KRAS.

  • Brings together wide ranging topics in RAS basic and translational biology for the scientific and clinical community
  • Showcases the recent advancement in RAS research under one comprehensive volume
  • Includes video clips, color illustrations, and important website links to facilitate clear understanding of RAS in cancer research
Number of Pages: 275
Genre: Medical
Format: Hardcover
Publisher: Elsevier Science Ltd
Author: Asfar Azmi
Language: English
Street Date: August 30, 2016
TCIN: 51697350
UPC: 9780128035054
Item Number (DPCI): 248-28-8144
If the item details above aren’t accurate or complete, we want to know about it. Report incorrect product info.

Guest reviews

Prices, promotions, styles and availability may vary by store & online. See our price match guarantee. See how a store is chosen for you.